Penumbra, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
PEN New York 3850 www.penumbrainc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Penumbra, Inc.

TFX vs. PEN: Which Stock Is the Better Value Option? - Sep 11th, 2026 9:40 am
TFX or PEN: Which Is the Better Value Stock Right Now? - Aug 26th, 2026 9:40 am
Which Medtech Giant Would Buy Inspire Medical Systems? - Aug 14th, 2026 3:54 pm
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure? - Aug 6th, 2026 12:16 pm
Penumbra, Inc. Reports Second Quarter 2026 Financial Results - Jul 30th, 2026 2:05 pm
Penumbra (PEN) Following THUNDERBOLT Debut, Is The Stock A Bargain Or Fairly Valued - Jul 25th, 2026 11:13 pm
Penumbra (PEN) Wins FDA Clearance For THUNDERBOLT After Strong Stroke Study - Jul 25th, 2026 4:12 pm
Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention - Jul 24th, 2026 6:30 am
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care - Jul 22nd, 2026 12:35 pm
3 Medical Device Stocks Giving Investors a Different Healthcare Play - Jul 20th, 2026 7:40 am
IQV vs. PEN: Which Stock Is the Better Value Option? - Jul 14th, 2026 9:40 am
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke - Jul 7th, 2026 7:00 am